Skip to main content

Day: February 18, 2020

Lokalplan for et nyt Lalandia i Søndervig er godkendt

I fortsættelse af selskabsmeddelelse 15/2018 af 19. december 2018 kan det oplyses, at byrådet i Ringkøbing Skjern Kommune i dag har godkendt lokalplanen for et nyt Lalandia i Søndervig.Dermed er alle godkendelser for projektets realisering opnået og Lalandia i Søndervig forventes at åbne inden sommeren 2022.Etableringen foretages gennem selskabet Lalandia Søndervig A/S, der ejes af PARKEN Sport & Entertainment A/S (75 %) og købmand Keld Hansen, Søndervig (25 %).Investeringen i Lalandia i Søndervig vil være ca. 400 mio. kr., hvortil kommer investeringerne i de 440 omkringliggende feriehuse, der dog afdækkes ved salg af feriehusene inden opførelse af feriecentret. De samlede investeringer vil udgøre ca. 1 mia. kr.Det estimeres, at projektet, herunder som følge af salg af feriehuse, vil have en positiv effekt på resultatet før skat i...

Continue reading

Puma Exploration to Drill the Chester Property in 2020

RIMOUSKI, Québec, Feb. 18, 2020 (GLOBE NEWSWIRE) — Puma Exploration Inc. (the “Company” or “Puma”) is pleased to announce that it elects to maintain the Chester Property option agreement in good standing and has fulfilled the minimum requirements for the first year anniversary as stipulated in the option agreement (see news 12/02/2019).During the first year work program, Puma proceeded with several exploration techniques including : geological mapping, extensive data compilation, 3D EM inversion, detailed AI targeting survey (Windfall Geotech WIN-TSXV), and a trenching program (4,500 m). Current exploration work completed by Puma was aimed to identify the best 5-10 targets to be drilled on the property during the second year program.The trenching program conducted on the Chester Property in November and December 2019 highlight and...

Continue reading

Transactions by members of senior management in shares issued by Columbus A/S and related securities

Release no. 3/2020Statement of transactions by members of senior management and their related parties in shares issued by Columbus A/S and related securities, cf. article 19 of the Market Abuse RegulationAttachmentSE_03_2020_Transactions_by_members_of_senior_management_in_shares_issued_by_Columbus_and_related_securities

Continue reading

Incentive scheme

Release no. 2/2020To strengthen Columbus A/S’s results and value creation for the company’s share­holders, and to attract, retain and motivate senior executives, and other key employees in Columbus, the Board of Directors has decided to exercise the authorization in Art. 5 in the Company’s Articles of Association and grant warrants amounting to a total value of DKK 3,881,250 (nom.) in Columbus A/S.The issue of warrants is in accordance with the Company’s remuneration policy, incl. guidelines for incentive programs which were adopted at the Company’s Annual General Meeting on 24 April 2018.The exercise price is based on the average quoted share price in the three trading days prior to the grant date.The warrants are granted to senior executives and other senior employees contingent on employment in the company in the below-mentioned vesting...

Continue reading

Sanofi joins forces with U.S. Department of Health and Human Services to advance a novel coronavirus vaccine

Sanofi joins forces with U.S. Department of Health and Human Services to advance a novel coronavirus vaccine*Work with Biomedical Advanced Research and Development Authority (BARDA) will utilize Sanofi’s well-established recombinant technology platform to expedite a potential COVID-19 vaccinePARIS – February 18, 2020 – Sanofi Pasteur, the vaccines global business unit of Sanofi, will leverage previous development work for a SARS vaccine which may unlock a fast path forward for developing a COVID-19 vaccine. Sanofi will collaborate with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response, expanding the company’s long-standing partnership with BARDA.COVID-19 belongs to a family of coronaviruses that can cause respiratory disease. In late 2002, the...

Continue reading

Sanofi s’associe au ministère américain de la Santé et des Services sociaux pour développer un vaccin contre le nouveau coronavirus

Sanofi s’associe au ministère américain de la Santé et des Services sociaux pour développer un vaccin contre le nouveau coronavirus*La collaboration avec la BARDA (Biomedical Advanced Research and Development Authority) fera appel à la technologie éprouvée de recombinaison de l’ADN de Sanofi pour accélérer la mise au point d’un vaccin potentiel contre le COVID-19.PARIS – Le 18 février 2020 – Sanofi Pasteur, l’entité mondiale Vaccins de Sanofi, va mettre à profit ses recherches antérieures sur le syndrome respiratoire aigu sévère (SRAS) pour tenter d’accélérer le développement d’un vaccin contre le COVID-19. Pour ce faire, Sanofi collaborera avec la BARDA (Biomedical Advanced Research and Development Authority ou Autorité   pour   la   Recherche-Développement   avancée   dans le domaine  biomédical), qui relève de l’Office chargé des préparatifs...

Continue reading

Revival Gold to Attend Conferences

TORONTO, Feb. 18, 2020 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQB: RVLGF) (“Revival Gold” or the “Company”), a growth‐focused gold exploration and development company, announces its participation in the following upcoming conferences:  BMO 29th Global Metals & Mining Conference to be held in Hollywood, Florida from February 23rd-26th, 2020 at The Diplomat Resort.  PDAC 2020 to be held in Toronto, Ontario from March 1st-4th, 2020 at The Metro Toronto Convention Centre. Revival Gold will be in booth IE2507. A corporate presentation will be given on March 3rd, 2020 at 3:30pm in the Gold Exploration Session 5 in Room 802, MTCC South Building.Interested parties that wish to schedule a meeting or who would like more information regarding the conferences and events noted above, please contact Melisa Armand...

Continue reading

Allied Announces February 2020 Distribution

TORONTO, Feb. 18, 2020 (GLOBE NEWSWIRE) — Allied Properties REIT (“Allied”) (TSX:AP.UN) announced today that the Trustees of Allied have declared a distribution of $0.1375 per unit for the month of February 2020, representing $1.65 per unit on an annualized basis.  The distribution will be payable on March 16, 2020, to unitholders of record as at February 29, 2020.Allied is a leading owner, manager and developer of (i) distinctive urban workspace in Canada’s major cities and (ii) network-dense urban data centres in Toronto that form Canada’s hub for global connectivity. Allied’s business is providing knowledge-based organizations with distinctive urban environments for creativity and connectivity.FOR FURTHER INFORMATION, PLEASE CONTACT:Michael R. EmoryPresident and Chief Executive Officer(416) 977-9002memory@alliedreit.comCecilia...

Continue reading

Pacific Rim Cobalt Secures Government Approvals

Highlights:Cyclops Nickel-Cobalt project license fully compliant under updated mining registration processNational, provincial and local support received for projectStrategic partner / investor discussions have commencedVANCOUVER, British Columbia, Feb. 18, 2020 (GLOBE NEWSWIRE) — Pacific Rim Cobalt Corp. (the “Company” or “Pacific Rim Cobalt”) (CSE: BOLT) (OTCQB: PCRCF) (FRANKFURT: NXFE) is pleased to announce it has received approval from the OMBUDSMAN of the Republic of Indonesia for the registration of the Cyclops Nickel-Cobalt Project license in the Directorate General of Minerals and Coal and the Ministry of Energy and Mineral Resources of the Republic of Indonesia.  The project license will be transferred into a Foreign Investment License where it will be administered by the central government. The license will then be fully...

Continue reading

Precipio in advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnership

NEW HAVEN, Conn., Feb. 18, 2020 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it is in advanced discussions with Poplar Healthcare to establish a strategic partnership that includes, among other transactions, the acquisition of the customer base of Poplar’s Hematopathology division, OncoMetrix.The planned transaction contemplates that Precipio will assume responsibility for OncoMetrix’s customer base and associated revenues of approximately $3M (as of YE 2019, unaudited). This will represent a potential doubling of Precipio’s current pathology services revenue, and should provide a substantial improvement to Precipio’s laboratory economies of scale, resulting in increased gross margins. Assuming discussions proceed on course, Precipio anticipates this transaction...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.